RAFAEL CALLANTA: Open Payments
NPI 1881935237 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,000 in 10 payments from 5 companies in 2025. Trend: 2023 $152 · 2024 $129 · 2025 $4,000
Long term medical supply or device loan: $3,808Food & beverage: $192
| Company | Payments | Amount |
|---|---|---|
| INTERNATIONAL REHABILITATIVE SCIENCES, INC | 2 | $3,822 |
| Forte Bio-Pharma LLC | 5 | $124 |
| ABBVIE INC. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| PROTEGA PHARMACEUTIALS INC | 1 | $16 |
Products named: RS-4i Plus with Intersperse, PROLATE, QULIPTA, XTAMPZA, ROXYBOND.
Industry payments across NV — which companies pay providers there.
